Detalhe da pesquisa
1.
Effect of dapagliflozin on COVID-19 infection and risk of hospitalization.
J Antimicrob Chemother
; 78(9): 2335-2342, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549309
2.
Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis.
J Cardiovasc Pharmacol
; 81(1): 70-75, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219195
3.
Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry.
Eur J Clin Invest
; 52(12): e13863, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36039486
4.
Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry.
J Cardiovasc Pharmacol
; 79(4): 523-529, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34983910
5.
Clinical Benefit of Bempedoic Acid in Randomized Clinical Trials.
Am J Cardiol
; 205: 321-324, 2023 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633067
6.
Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World-MEMOGAL Study.
Am J Cardiovasc Drugs
; 23(5): 583-593, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37612529
7.
Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase.
Prim Care Diabetes
; 17(4): 366-372, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230813
8.
Semaglutide versus GLP-1 agonists. Effectiveness, safety, and quality of life in patients with diabetes mellitus 2. The SEVERAL study.
Farm Hosp
; 46(6): 372-379, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36520578
9.
Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors. / Impacto de la pandemia por COVID-19 en el control lipídico de pacientes que inician inhibidores de la PCSK9.
Clin Investig Arterioscler
; 34(5): 245-252, 2022.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-35287972
10.
Observational multicentre prospective study to assess changes in cognitive function in patients treated with PCSK9i. Study protocol.
Farm Hosp
; 45(3): 150-154, 2021 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33941059
11.
Estimation of the major cardiovascular events prevention with Inclisiran.
Atherosclerosis
; 313: 76-80, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33032236
12.
Prevention of myocardial infarction and stroke with PCSK9 inhibitors treatment: a metanalysis of recent randomized clinical trials.
J Diabetes Metab Disord
; 19(2): 759-765, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33520801
13.
Mid-range Ejection Fraction Does Not Permit Risk Stratification Among Patients Hospitalized for Heart Failure.
Rev Esp Cardiol (Engl Ed)
; 70(5): 338-346, 2017 May.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-28011188